Rocket Pharmaceuticals Inc (RCKT)
21.86
-1.02
(-4.46%)
USD |
NASDAQ |
Jun 14, 16:00
21.86
0.00 (0.00%)
After-Hours: 18:57
Rocket Pharmaceuticals Price to Book Value: 4.495 for June 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 13, 2024 | 4.705 |
| June 12, 2024 | 4.674 |
| June 11, 2024 | 4.711 |
| June 10, 2024 | 4.596 |
| June 07, 2024 | 4.664 |
| June 06, 2024 | 4.727 |
| June 05, 2024 | 4.750 |
| June 04, 2024 | 4.571 |
| June 03, 2024 | 4.509 |
| May 31, 2024 | 4.384 |
| May 30, 2024 | 4.411 |
| May 29, 2024 | 4.248 |
| May 28, 2024 | 4.306 |
| May 24, 2024 | 4.404 |
| May 23, 2024 | 4.466 |
| May 22, 2024 | 4.614 |
| May 21, 2024 | 4.592 |
| May 20, 2024 | 4.694 |
| May 17, 2024 | 4.651 |
| May 16, 2024 | 4.812 |
| May 15, 2024 | 4.865 |
| May 14, 2024 | 4.807 |
| May 13, 2024 | 4.748 |
| May 10, 2024 | 4.672 |
| May 09, 2024 | 4.797 |
| Date | Value |
|---|---|
| May 08, 2024 | 4.725 |
| May 07, 2024 | 4.803 |
| May 06, 2024 | 4.770 |
| May 03, 2024 | 4.826 |
| May 02, 2024 | 4.682 |
| May 01, 2024 | 4.633 |
| April 30, 2024 | 4.423 |
| April 29, 2024 | 4.491 |
| April 26, 2024 | 4.518 |
| April 25, 2024 | 4.543 |
| April 24, 2024 | 4.857 |
| April 23, 2024 | 4.865 |
| April 22, 2024 | 4.906 |
| April 19, 2024 | 4.686 |
| April 18, 2024 | 4.826 |
| April 17, 2024 | 4.867 |
| April 16, 2024 | 4.984 |
| April 15, 2024 | 4.930 |
| April 12, 2024 | 4.966 |
| April 11, 2024 | 5.190 |
| April 10, 2024 | 5.014 |
| April 09, 2024 | 5.205 |
| April 08, 2024 | 5.008 |
| April 05, 2024 | 5.135 |
| April 04, 2024 | 5.129 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.255
Minimum
May 11 2022
14.78
Maximum
Dec 22 2020
4.119
Average
3.795
Median
Price to Book Value Benchmarks
| Ligand Pharmaceuticals Inc | 1.781 |
| ACADIA Pharmaceuticals Inc | 5.305 |
| Alnylam Pharmaceuticals Inc | -- |
| United Therapeutics Corp | 2.395 |
| ADMA Biologics Inc | 16.03 |
Price to Book Value Related Metrics
| Price | 21.86 |
| Earnings Yield | -13.13% |
| Market Cap | 1.984B |